Aratana Therapeutics's competitors

Aratana Therapeutics's competitors include Pfizer, Ncardia, Caladrius and Zoetis
Add company...
Aratana Therapeutics
Aratana Therapeutics is a pioneer in pet therapeutics focused on licensing, developing and commercializing innovative therapeutics for dogs and cats.
Pfizer
Pfizer is a biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.
Ncardia
Ncardia is a stem cell drug discovery and development company.
Caladrius
Caladrius is a biopharmaceutical company developing cellular therapies for the oncology, immunology, and regenerative medicine sectors.
Zoetis
Zoetis, Inc. is the producer of medicine and vaccinations for pets and livestock.
Founding Date
Founding Date
2010
Founding Date
1849
Founding Date
2010
Founding Date
2006
Founding Date
1952
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Leawood, US HQ
Leuven, BE
San Diego, US
Locations
New York, US HQ
Buenos Aires, AR
Melrose Park, AU
Wien, AT
Minsk, BY
Ixelles, BE
Sofia, BG
see more
Locations
Gosselies, BE HQ
Köln, DE
Leiden, NL
Plymouth Meeting, US
Locations
Bernards, US HQ
New York, US
Locations
Parsippany-Troy Hills, US HQ
Employees
Employees
85 52% increase
Employees
90,200 7% decrease
Employees
54 10% increase
Employees
209
Employees
9,200 2% increase
Valuation ($)
Valuation ($)
211.5 m
Valuation ($)
221.1 b
Valuation ($)
N/A
Valuation ($)
34.4 m
Valuation ($)
42.4 b
Facebook likes
Facebook likes
N/A
Facebook likes
320.2 k
Facebook likes
N/A
Facebook likes
3.7 k
Facebook likes
37.9 k
Twitter followers
Twitter followers
560
Twitter followers
13.3 k
Twitter followers
566
Twitter followers
1.6 k
Twitter followers
10 k

Financial

Revenue (est.)
Revenue (est.)
$25.6m (FY, 2017)
Revenue (est.)
$52.8b (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$5.3b (FY, 2017)
Cost of goods
Cost of goods
$16.4m (FY, 2017)
Cost of goods
$12.3b (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$1.8b (FY, 2017)
Gross profit
Gross profit
$9.2m (FY, 2017)
Gross profit
$40.5b (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Gross profit
$3.5b (FY, 2017)
Net income
Net income
($47.5m) (FY, 2017)
Net income
$7.2b (FY, 2016)
Net income
N/A
Net income
$22.2m (FY, 2017)
Net income
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles